 |
|
|
Lundbeck
Call: 0870 2410536
Vacancies:
click
here
Zenith Recruitment
Call: 01494 818000
Vacancies:
click
here
PharmaForce
Call: 01844 202 010
Vacancies:
click
here
PCC
Call: 0870 240 3038
Vacancies:
click
here
CD Sales Recruitment
Call: 020 8722 8200
Vacancies:
click
here
Guided Solutions
Call: 0870 751 2238
Vacancies:
click
here
Taylor Tomkins Britton
Call: 01628 488 533
Vacancies:
click
here
Seltek Consultants
Call: 01279 657716
Vacancies:
click
here
Advance Recruitment
Call: 0800 783 0920
Vacancies:
click
here
Scientific Staff
Call: 020 7242 4266
Vacancies:
click
here
UKPharm
Call: 0870 2410536
Vacancies:
click
here
Adderley Featherstone
Call: 01937 841 402
Vacancies:
click
here |
|
|
Clinical
Service Advisor (CSA)
Lanarkshire
Tel: 01494 818000
Theatre
Sales Executive (South East)
Theatre sales and orthopaedic
representative required to cover half of the South East of the UK. Product
portfolio includes, power tools, lights
Tel: 01628 488 533
RBM
(South)
Tel: 0870 751 2238
Hospital
Sales Specialists (Sth East / Sth Thames)
With integrity, energy and the
stature to build positive customer relationships, you must be comfortable
working within a clinical environment
Tel: 01937 841 402
Product
Manager (UK)
Working from both the office and out in the field, you will
be responsible for liasing closely with customers and solving technical
queries, working
Tel: 0870 751 2238
Regional
Sales Manager (Central Division)
Leading manufacturer of incontinence
products requires RSM to cover central region responsible for 4 sales execs and
a team of clinical advisors.
Tel: 01628 488 533
Sales
Specialist (South Yorks and Trent)
Selling Oncology related Ethical and
Medical products into NHS Trusts and Hospitals within the South Yorkshire and
Trent area. Dealing with
Tel: 0870 751 2238
Associate
Product Manager (Bedfordshire)
Tel: 01494 818000
Medical
Sales Part Time (UK Nation-wide)
Part time medical sales representative
required for Innovative CSO. Calling on GP's, Pharmacist's and Practice
Nurses.
Tel: 0870 2410536
Healthcare
Development Executive (Trent)
Tel: 01494 818000
Hospital
Specialist (North London, Essex, Wiltshire)
Selling a range of
market-leading ophthalmics pharmaceuticals to Ophthalmic Consultants in
secondary care. The company is launching a brand new...
Tel: 0800 783 0920
Medical
rep (York)
Developing core brands through selling to customers in
primary and secondary care. Meeting sales and activity targets
Tel: 0870
240 3038
Product
Specialist (S Wales, Part W Mids, S W)
You will sell the companies range
of products into hospitals on territory, the majority of your time will be
spent in theatre at the side of general...
Tel: 0800 783 0920
Medical
Representative (Somerset & East Devon)
Tel: 01494 818000
NHS
Liaison Representative (South London)
The role involves dealing at PCO /
PCT level, negotiating & gaining endorsements for The products, as well as
liaising with the hospital team & doing a...
Tel: 0800 783
0920
Regional
Territory Manager (Southern)
Our client is a well established and
reliable supplier of biomedical tools to research and industry. They are a
responsible partner in all areas of...
Tel: 01953 453753
Territory
Manager (Kent/Sussex) - Selling near patient blood glucose testing kits
into primary and secondary care. Date posted: 14/11/03
Regional
Account Manager - Dispensing (South East)
Immediate requirement for a
Dispensing Practice Sales Specialist to cover the South East. You will
demonstrate a track record of success within a...
Tel: 020 7242
4266
Medical
Imaging (North Midlands)
Our client is a leading provider of medical
imaging and diagnostic equipment to the NHS and private hospital market. A rare
and exciting opportunity...
Tel: 020 8722 8200
P/Time
Medical Sales (Suffolk :: Lincolnshire)
Part-time opportunities: Suffolk
& Lincolnshire (+Nationwide) for experienced Medical Sales Professionals
and Trainees. Lundbeck is the only...
Tel: 0870 241 0536
Product
Specialist (South West London)
Urgently looking for a hospital
specialist to cover London and the home counties.
Tel: 01483 243589
Sales
Executive (Lincolnshire and Nottingh)
Market leading manufacturer of
woundcare products requires a sales executive to sell products to Hospitals and
GPs
Tel: 01628 488 533
Business
Deveopment Executive (South East)
2003 sees the development of a
Nation-wide team of ¡¥ Business Development Managers¡¦
whose role is to report directly to the RBM covering all PCOs...
Tel: 01844
202010
Hospital
Specialist (South West)
Role Selling a range of market-leading
ophthalmics pharmaceuticals to Ophthalmic Consultants in secondary care. The
company is launching a...
Tel: 0800 783 0920 |
|
|
OnTarget
Mag
Clinical
Research Focus
Drug
Discovery |
|
|
Rheumatoid
arthritis: Emerging drug discovery targets and therapeutic candidates
Getting
to grips with online career management - a candidate perspective
All
you need to know about part-time medical sales
NLP
- Five essential steps
Taming
the growing stress monster
Accessing
the inaccessible |
|
|
On Target
For
people who work to live in the medical and pharma industries.
Get Alexa
Toolbar
Through our partnership with Amazon.com, we are offering an
exclusive version of the award winning Alexa toolbar.
Free
text messaging
Why pay for SMS text messages, when you can send them for
free?
|
|
|
|
Nokia
6600: This stylish new handset primarily aimed at business users is a
sophisticated camera phone featuring advanced functionality, large colour
screen, digital zoom and video recorder.
Click
here for more information. |
|
|
|
NHS Local - November 2003
Local NHS
News - an overview of interesting stories
from PCTs during the last
month.
from Health Direction
Pharma
NewsBytes - November 2003
Selected Pharmaceutical press
releases
from LeadDiscovery [read]
|
| |
Local NHS
Intelligence - November 2003.
By Duncan Alexander of Health
Direction |
|
Blackburn with Darwen PCT - New Repeat Dispensing
Scheme
The new system of repeat dispensing means that prescriptions can
be dispensed in intervals by community pharmacists. The pharmacist can prepare
prescriptions when convenient, and it's often easier for the patient to collect
them from the pharmacy. |
|
Brighton and Hove City PCT / Adur, Arun and Worthing PCT -
Teaching Status
Joint Teaching status has been awarded to these two
PCTs, together with a £370,000 grant. The neighbouring PCTs share similar
demographics and a workforce, as well as difficult health challenges and a
number of poor health issues. |
|
Buckinghamshire Mental Health NHS Trust - Memory Clinic
Pilot Project
The Memory Clinic opened on 10 September and is based at
the John Hampden Unit. It is part of a 6-month pilot project and follows the
success of an earlier scheme led by local practitioners, intended to raise
awareness of the early symptoms of dementia. |
|
Central Liverpool PCT - Cervical Screening
Campaign
Central Liverpool PCT have been giving away free knickers in
the city centre to encourage young women to have a cervical smear test. Four
out of 10 Liverpool women aged between 25 and 29 haven't had an adequate smear
test in the last 5 years. |
|
Croydon PCT - NHS Mammography Suite in Local Department
Store
Allders in Croydon now has an NHS Mammography Suite in store. The
service is provided by the South West London Breast Screening Service (St
George's Healthcare NHS Trust). The PCT hopes to establish a permanent
screening site in Purley next year. |
|
Professional Careers Consulting [web-site]
Are you a dynamic and successful Medical
Sales Professional?
Does your customer focus and knowledge stand you apart
from the crowd?
Are you are looking to further develop your career?
Call now on: 0870 240 3038 or
click here to
view our current opportunities |
|
|
Eastbourne Downs PCT - Community Pharmacists/Medicines
Management Trial
Community Pharmacists are to be encouraged to contact
GPs more often to suggest prescription changes. Examples include dose
optimisation, duplication and cost-effective alternatives, and savings could
mount to £30k per year. [click
here to read more] |
|
Fareham and Gosport PCT - Community Pharmacy
Service
The PCT's Community Pharmacy Service visits patients at home,
and the pharmacist removes medicines which are out of date or no longer
required. This service is to be extended to all elderly patients discharged
from hospital with more than 3 medications. |
|
Harlow PCT - Waiting List Reduction for
Vasectomy
Harlow PCT has reduced the vasectomy waiting list by
two-thirds by moving the service into primary care from the hospital and
keeping in touch with patients. One afternoon a week was set by at a local
practice's operating room with a GP from a nearby PCT. [click
here to read more] |
|
High Peak and Dales - 48-Hour Access Target
Dr Peter
Holden of the Matlock Surgery is among those doctors whose surgeries no longer
offer pre-booked appointments in order to to ensure that every patient who
requests an appointment can be seen within the 48-hour NHS target. [click
here to read more] |
|
Ipswich Hospital NHS Trust - COPD Pilot
The new
Outreach Respiratory Team at Ipswich Hospital NHS Trust will support people
with chronic respiratory problems in their own homes, after being discharged
from hospital. This is a whole protocol of care for people with COPD and is a
six-month pilot. [click
here to read more] |
|
London - The
Big Smoke Debate
The Big Smoke Debate is run by London Health
Commission. It is asking people who live and work in London for their opinions
on passive smoking - WHERE smoking should occur rather than IF it should - and
is the biggest consultation of its kind in the UK. |
|
Mersey Care NHS Trust - New Asperger's
Team
Asperger's syndrome is a variant of Autism, and this is the first
health-funded Asperger's Team in the country. The multi-disciplinary team is
based at Olive Mount Hospital, Wavertree and will, initially, only be available
to people in the Liverpool area. |
|
North Bradford PCT - Health Service Journal
Award
After winning the Primary Care category at this year's HSJ awards,
North Bradford PCT went on to win the overall award, the Prime Minister's Award
for Excellence in Healthcare Management, with their project on primary care
performance improvement. |
|
Nottingham City PCT - MRSA Training Session for
GPs
Nottingham City PCT has organised training courses on infection
control for GPs and Practice Nurses in a bid to combat the growth of MRSA in
general practice. The courses are aimed primarily at nurses who often deal with
dressings and wounds. [click
here to read more] |
|
Rushcliffe PCT - Cancer Register Pilot
A Cancer
Strategy Group has been formed at Rushcliffe PCT, and a Cancer Forum is
planned. GP practices have also been invited to join local trials of a Primary
Care Cancer Register. |
|
Rushcliffe PCT - Diabetes Forum
The new Diabetes
Forum has been set up so that interested local people can discuss their
experiences and help to improve services. The first meeting will feature talks
from the Director of Public Health, a representative from Diabetes UK and a
local GP. |
|
South Liverpool PCT - Head of Learning and
Development
Angela Delea has been appointed Head of Learning and
Development. She will take responsibility for the training and development of
all staff at South, Central and North Liverpool PCTs as well as some staff at
South Sefton PCT. |
|
South London PCTs / South London HIV Partnership - New Range
of Services
A new range of HIV Support Services were due to start in
October, following a detailed needs assessment of service provision. Groups
which have been targeted include women, African communities, children and young
people. [click
here to read more] |
|
Southport and Formby PCT - Lymphoedema Specialist
Nurse
Vicky Hindley, the new Lymphoedema Specialist Nurse at the PCT,
will be working in the community as well as at the local hospital and hospice.
She hopes to develop the service, and set up new clinics in Church Street
(Southport) and in West Lancashire. |
|
|
2nd Annual Sales Force
Effectiveness Conference [website]
Eyeforpharma's
2nd Annual Sales Force Effectiveness Conference will tackle the hottest issues
challenging your company both now and in the future! Already experiencing
fantastic success from this years event, eyeforpharma are extremely positive
that by attending this major calendar event, in just two fact filled days you
can get to grips with the key strategies that will increase your bottom line
and make your sales force dramatically more effective.
For further
information: email or telephone
+44 (0) 20 73 75 75 75.
Website:
www.eyeforpharma.com/sales2004/.
|
|
|
Sutton and Merton PCT - Award
Annie Hoile is a
Specialist HIV Nurse whose work also covers Richmond and Twickenham PCT and
Wandsworth PCT. She has won an excellence award from the South West London SHA
for the specialist HIV Nursing Service she set up 14 years ago. |
|
United Lincolnshire Hospitals NHS Trust - Cancer/Palliative
Care
Kathy Blythe is the new Macmillan Lead Nurse at Lincoln County
Hospital. Part of her remit is to extend the cancer care services the county's
GP surgeries. It is hoped that a new Palliative Care GP and Palliative Care
Nurse will soon be appointed. [click
here to read more] |
|
Wandsworth PCT - Award
South West London SHA has
presented a series of local NHS Excellence awards. The reception team at The
Surgery, Queenstown Road, Battersea have developed their roles so that five can
perform initial interviews and two are trained phlebotomists. |
|
About the author
Health Direction Ltd is entirely
focused on collecting, processing and analysing high quality UK-based health
information for dissemination through intuitive, browser-based products via the
internet, company intranet and CD-Rom. Privately owned and run you will find
our staff friendly, knowledgeable and helpful. We put customer satisfaction at
the top of our agenda.
If you have a requirement for NHS information,
contact
Health
Direction. |
Pharma NewsBytes -
November 2003
Selected Pharmaceutical press releases from
LeadDiscovery
The battle for the anti-hyperlipidemia
market
In October AstraZeneca announced early figures concerning the
sale of Crestor following its US launch in September . Although positive, these
were put in context nn November 12th when Pfizer released clinical data on
Lipitor, Crestor's biggest competitor and indeed the world's top-selling
medicine. The Pfizer study, "The Reversing Atherosclerosis with Aggressive
Lipid Lowering (REVERSAL) study" presented at the annual meeting of the
American Heart Association followed 502 patients, who were diagnosed with
coronary heart disease and required cardiac catheterization, or angiograms.
Patients in the 18-month study had at least one arterial vessel with 20 percent
or more constriction due to plaque build up. The study compared the
effectiveness of Lipitor (80 mg/day) versus Pravachol (40 mg/day) in reducing
plaque build-up. Lipitor-treated patients experienced a median 0.4% reduction
in total plaque volume. "These results clearly show that aggressively lowering
cholesterol levels with atorvastatin calcium stopped the progression of
atherosclerosis," said Dr. Steve Nissen, Medical Director of the Cleveland
Clinic Cardiovascular Coordinating Center and Principal Investigator of the
REVERSAL study. "This study further demonstrates the benefits of aggressively
managing cholesterol levels to reduce the risk of atherosclerosis" [news article]
Recent surges in rheumatoid
arthritis development activity
October/November proved to be big in
rheumatoid arthritis news, coinciding with the Annual American College of
Rheumatology meeting. LeadDiscovery's recent state of the art analysis of
emerging rheumatoid arthritis therapeutics evaluates many of the new molecular
targets for this disease (click here), one of which is the MCP-1/CCR2 chemokine
pathway. On October 14th Millennium announced the initiation of a multicenter
phase II clinical trial of MLN1202, their novel humanized monoclonal antibody
which is specifically designed to block this pathway. Primary objectives of
this double-blind, placebo-controlled, multiple dose-escalation study in
approximately 30 patients with rheumatoid arthritis are to assess the safety,
tolerability, pharmacokinetic, pharmacodynamic properties and biological
activity of MLN1202 via synovial biopsy. The study will be conducted in Europe
and Australia. A phase I single dose-escalation study was initiated in December
2002 to evaluate the tolerability, pharmacokinetic and pharmacodynamic effects
of MLN1202 in healthy volunteers. MLN1202 was well tolerated and no
drug-related serious adverse events were reported among the 48 volunteers in
that study. In that study, MLN1202 also demonstrated predictable dose-dependent
pharmacokinetics and significant blockade of the MCP-1/CCR2 pathway. "Our
confidence in the initial data we have reviewed has encouraged us to move
MLN1202 rapidly into phase II trials, only nine months after the initiation of
the phase I trial," said Arthur Hiller, vice president, global strategic
marketing at Millennium. "Rheumatoid arthritis remains a significant area of
unmet medical need and we are hopeful that MLN1202's novel mechanism of action
may someday provide patients with a new treatment option". The MCP-1/CCR2
pathway plays a central role in the pathogenic inflammatory response cycle of
cell signaling, activation and amplification of inflammation. CCR2 receptors
are found on the surface of monocytes, macrophages and T-cells and bind
monocyte chemoattractant proteins (MCPs). By binding to the CCR2 receptor, MCPs
signal monocytes and T-cells to migrate to sites of injury as part of the
inflammatory process. MLN1202 is designed to specifically block the MCP-1/CCR2
chemokine pathway and prevent infiltration of immune cells into inflammatory
sites, such as arthritic joints [news article].
Depressing news for
anti-depressants
Following on from the adverse effect reported for
Merck & Co's Vioxx (see above), the US drug giants run of dissappointing
news continued with an announcement that it is discontinuing its Phase III
clinical development program for its NK1 receptor antagonist, MK-0869, for the
treatment of depression. The Phase III clinical program was halted because the
compound failed to demonstrate efficacy for the treatment of depression. "There
are significant challenges in scientific research, and unfortunately, sometimes
disappointments," said Peter S. Kim, Ph.D., president, Merck Research
Laboratories. "While we had reason to believe that the compound could be
effective in the treatment of depression, the results of the Phase III trials
did not demonstrate efficacy. Although Merck will not be continuing its
clinical development program for MK-0869 in depression, we remain committed to
our neuroscience research programs at our facilities in the United States and
the United Kingdom," he said [news article]. |
|
About the author
LeadDiscovery offers a unique
combination of technology mining and target discovery, on-line technology
transfer and drug development, our aim is to feed pharmaceutical pipe-lines
through the identification of exploitable research or academic/biotech
partners. Our free
DailyUpdates
service provides daily publication tracking for the drug discovery
community.
If you have a requirement for drug discovery information,
contact LeadDiscovery |
|
Disclaimer
OnePharm Internet excludes any
warranty, express or implied, as to the quality, accuracy, timeliness,
completeness or fitness for a particular purpose of this briefing. OnePharm
Internet will not be liable for any claims, penalties, losses, damages, costs,
or expenses arising from the use of or inability to use this briefing or from
any unauthorised access to or alteration of the Briefing. OnePharm Internet
makes no warranty that the contents of this briefing are compatible with all
computer systems and browsers.
You have received this free newsletter
because your e-mail has been submitted via
MedicalSalesFocus.co.uk,
PharmaReview.co.uk,
AllAboutMedicalSales.com,
JobsPharm.com or one of
our partner sites.
If you have received this communication in error or
wish to 'unsubscribe' - please follow the directions at the end of this
newsletter and we will remove your details from our
database.
|
|
|
